Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05300048
Title	Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Faeth Therapeutics
Indications	endometrial adenocarcinoma endometrial serous adenocarcinoma endometrial carcinoma ovarian clear cell carcinoma rectum adenocarcinoma endometrial squamous cell carcinoma colon adenocarcinoma Advanced Solid Tumor uterine carcinosarcoma endometrioid ovary carcinoma endometrial transitional cell carcinoma endometrial clear cell adenocarcinoma
Therapies	Serabelisib Nab-paclitaxel + Serabelisib
Age Groups:	senior \| adult
Covered Countries	USA